연구

연구업적

최근 5년 연구업적 현황
연도 2025년 2024년 2023년 2022년 2021년
SCI 논문
발표편수
책임 196편 179편 173편 163편 184편
공동 132편 147편 120편 115편 136편
합계 328편 326편 293편 278편 320편
1625. ACT findings of minimally invasive adenocarcinoma (MIA) of the lung and comparison of solid portion measurement methods at CT in 52 patients.
Lee SM, Goo JM, Lee KH, Chung DH, Koh J, Park CM
Eur Radiol. 2015 Aug;25(8):2318-2325. Link
1624. Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.
Moon HH, Kim SH, Ku JL
Oncol Rep. 2016 Jan;35(1):298-306. Epub 2015 Oct 21. Link
1623. High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma.
Hong CR, Kang HJ, Kim MS, Ju HY, Lee JW, Kim H, Kim HS, Park SH, Park KD, Park JD, Shin HY, Ahn HS.
Bone Marrow Transplant. 2015 Oct;50(10):1375-8. Link
1622. Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation.
Kim H, Shin D, Kang HJ, Yu KS, Lee JW, Kim SJ, Kim MS, Song ES, Jang MK, Park JD, Jang IJ, Park KD, Shin HY, Ahn HS.
Clin Drug Investig. 2015 Jul;35(7):437-46. Link
1621. Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial.
Kang HJ, Loftus S, Taylor A, DiCristina C, Green S, Zwaan CM.
Lancet Oncol.2015 Apr;16(4):385-94. Link
1620. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily IV busulfan fludarabine etoposide regimen in pediatric and infant ALL patients.
Lee JW, Kang HJ, Kim S, Lee S, Yu KS, Kim NH, Jang MK, Kim H, Song SH, Park JD, Park KD, Shin HY, Jang IJ, Ahn HS.
Biol Blood Marrow Transplant. 2015 Jan;21(1):190-5. Link
1619. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway.
Bae JM1, Kim JH1, Rhee YY1, Cho NY1, Kim TY1, Kang GH1.
World J Gastroenterol. 2015 Sep 7;21(33):9749-57. doi: 10.3748/wjg.v21.i33.9749. Link
1618. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH1, Cho NY2, Bae JM3, Kim KJ3, Rhee YY3, Lee HS4, Kang GH5.
Int J Clin Exp Pathol. 2015 Feb 1;8(2):1920-8. eCollection 2015. Link
1617. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.
Kim Y1, Bae JM2, Li G1, Cho NY2, Kang GH3.
PLoS One. 2015 Apr 15;10(4):e0122183. doi: 10.1371/journal.pone.0122183. eCollection 2015. Link
1616. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY1, Lee TH, Song YS, Wen X, Kim H, Jheon S, Lee CT, Kim J, Cho NY, Chung JH, Kang GH.
Virchows Arch. 2015 Jun;466(6):675-83. doi: 10.1007/s00428-015-1749-0. Epub 2015 Mar 13. Link